IndraLab

Statements

MSAB inhibits YOD1. 1 / 1

| 1

reach

"Oral administration of β-catenin inhibitor MSAB (20 mg/kg, every other day for four weeks) eliminated the protective effect of YOD1 deletion on vascular endothelial injury."

38641745

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

MSAB inhibits YOD1. 1 / 1

INDRA sources:

Databases

Reading